Neoplasm Metastasis  >>  darleukin (L19IL2)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
darleukin (L19IL2) / Philogen
NCT01253096 / 2009-014799-23: Intratumoral Application of L19IL2 in Patients With Malignant Melanoma

Completed
2
25
Europe
Intratumoral injections of L19IL2
Philogen S.p.A.
Malignant Melanoma
09/13
09/13

Download Options